Home · Open Lab · Lot RGX-26-IPAMORELIN-656
RGX-26-IPAMORELIN-656Superseded
Ipamorelin · 5 MG · Endocrine Research · COA NS-2026-05164

Release test results

99.698%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 5.03 mg
Related impurities (total)0.302%
Endotoxin<1.0 EU/mg
HPLC retention time7.62 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundIpamorelin
Presentation5 MG
Lot numberRGX-26-IPAMORELIN-656
COA numberNS-2026-05164
Test date04 Sep 2026
Release date07 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Ipamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-IPAMORELIN-65510 MGSep 8, 202699.553%Superseded
RGX-26-IPAMORELIN-7565 MGSep 5, 202699.584%Superseded
RGX-26-IPAMORELIN-104510 MGSep 4, 202699.715%Current
RGX-26-IPAMORELIN-656 this lot5 MGSep 4, 202699.698%Superseded
RGX-26-IPAMORELIN-10445 MGSep 3, 202699.608%Current
RGX-26-IPAMORELIN-75510 MGSep 2, 202699.660%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →